CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [ChIP-Seq]
Ontology highlight
ABSTRACT: MCF7 were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 or DMSO and ChIP-seq was performed for H3K27ac and H3K9ac.
ORGANISM(S): Homo sapiens
PROVIDER: GSE190161 | GEO | 2022/03/04
REPOSITORIES: GEO
ACCESS DATA